Purpose: Pigment in the midretina is a characteristic sign in Type 2 idiopathic macular telangiectasia (MacTel) and is considered to characterize the late stage of the disease. Our aim was to investigate its incidence, and relationship with risk factors for MacTel, including outer retinal vascularization and subretinal neovascular proliferation (SRNV).
T ype 2 idiopathic macular telangiectasia (MacTel) is a bilateral, potentially blinding retinal disease of unknown etiology and pathogenesis, with no proven treatment at present. [1] [2] [3] As the name suggests, MacTel was long considered a vascular disease, as most signs of the disease apparent on biomicroscopy, color fundus photography (CF), and fundus fluorescein angiography (FFA) record vascular features, including telangiectatic capillaries, dilated venules, blunted and right-angle veins, associated with outer retinal vascularization (analogous to that demonstrated in animals with neuroglial disease 4, 5 ), early-phase fluorescein leakage, and late-phase staining. Later-stage complications may include subretinal neovascular proliferation (SRNV) with subsequent scarring and atrophy. More recent imaging modalities and histological evidence have revealed the neurodegenerative aspects of the disease and have led to a shift in the paradigm of the pathogenesis toward a primarily neurodegenerative disease, 3 with prominent involvement of retinal Müller cells. [6] [7] [8] Dualwavelength autofluorescence (AF) showed a progressive loss/redistribution of luteal pigment. [9] [10] [11] [12] Blue-light reflectance imaging revealed higher reflectivity in a specific pattern within the parafovea, which closely matches that of luteal pigment loss. 13 Optical coherence tomography (OCT) demonstrated low-reflective spaces in the inner and the outer retina and progressive atrophy and restructuring of the outer retina, characterized by a discontinuity ("break") in the line attributed to the photoreceptor inner segment ellipsoids (ellipsoid zone) 14 and an apparent "collapse" of the disorganized inner retina through this "break" toward the retinal pigment epithelium (RPE). [15] [16] [17] One clinical sign that was described early is the accumulation of pigment within the retina. 1 This pigment appears in CF images as brown, gray, or black, typically presents temporal to the foveal center, and is always adjacent to abnormal blood vessels. In later disease, it grows into "plaques" located in the midretina (see Figures 1 and 2) . 18 According to the current concept of the natural history of the disease, pigment is considered an obligatory sign of the disease, indeed Stage 4 in the system devised (in 1993) by Gass and Blodi 2 for staging disease severity in MacTel is defined by the presence of pigment alone.
Pigment is detectable using multiple imaging modalities. In CF images, it can be distinguished from scar tissue or retinal blood based on its color. In FFA images, it blocks AF and appears dark. It is highly reflective in OCT, blocking the path of light and thus casting "shadows" on tissues distal to its location. Its proximal edge is, however, indicative of its location within the retinal layers.
The full lateral extent of pigment plaques is very well demonstrated by fundus autofluorescence (FAF) imaging. Fundus AF emanates from components of lipofuscin within the RPE. 19, 20 Pigment deposits within the retinal layers internal to the RPE block autofluorescent light and appear as localized areas of decreased FAF, usually surrounded by an area of increased FAF (an "atrophic halo"). 21 Heidelberg Engineering incorporated in the native software of the Spectralis series of scanning laser ophthalmoscope (+OCT) machines (Heidelberg Eye Explorer, Heyex), a software tool for measuring the area of decreased AF in FAF images (Region Finder). This tool has been validated for measuring the area of geographic atrophy in age-related macular degeneration. 22, 23 However, Region Finder can also be used for measuring the size of any low-intensity lesion with a reasonably sharp gradient/boundary, including intraretinal pigment in MacTel.
Our aim was to investigate the presence and progression characteristics of abnormal pigmentation in the natural history of MacTel.
Participants and Methods

Study Participants
Patients with a confirmed diagnosis of MacTel were selected from the cohort of an international multicenter prospective natural history observational study of MacTel. 24 For an analysis of the involvement of pigment in the natural history of the disease, the grading database of the full MacTel cohort was analyzed. Of 1,244 right and an equal number of left eyes 488 and 447 eyes (39.2 and 35.9%), respectively, demonstrated pigment at least at one point in time during follow-up. For a detailed analysis of pigment extent, patients were selected based on the presence of pigment and the availability of good quality CF, fluorescein angiography, AF, and OCT imaging and at least 1 year of follow-up. The study protocol adhered to the tenets of the Declaration of Helsinki and was approved by respective local institutional ethics committee at each participating center. Written informed consent was obtained from each participant after explanation of the nature of the study.
Imaging
Standard 30°stereoscopic field 2 (centered on the fovea) color, red-free (RF), and fluorescein angiographic images of the fundus were recorded digitally using fundus cameras. Fundus AF was recorded using Heidelberg Retina Angiograph II or Heidelberg Spectralis scanning laser ophthalmoscope (+OCT) scanning laser ophthalmoscope systems (Heidelberg Engineering GmbH, Heidelberg, Germany). Spectral domain OCT analyzed for the presence of an ellipsoid zone break were either crosshair scans of the retina through the foveal center acquired using Heidelberg Spectralis OCT systems (Heidelberg Engineering GmbH) or 5-line raster scans centered on the fovea, recorded using Carl Zeiss Meditec Cirrus SD-OCT4000 systems (Carl Zeiss Meditec, Dublin, CA).
Phenotyping
Characteristics of the phenotype were analyzed using overlay grids according to the International Classification for age-related maculopathy and age-related macular degeneration, 25 counting the number of subfields affected by each sign. Early-phase FFA images were graded for lateral extent of vascular abnormalities characteristic of Type 2 MacTel including dilated retinal capillaries, telangiectatic vessels, dilated, blunted and right-angle veins, and fluorescein leakage. Late-phase FFA images were graded for extent of hyperfluorescence according to the same pattern as early FFA changes. 24 The presence and position relative to the foveal center (on/off) of a break in the ellipsoid zone (a.k.a. the IS/OS line) was graded in horizontal spectral domain OCT B-scans traversing the fovea. The extent of intraretinal pigment was measured using the Region Finder tool of Heidelberg Eye Explorer (Figure 3) . Repeatability data for the use of Region Finder (in geographic atrophy and Stargardt disease) have been published previously. 23, 26 Hypoautofluorescence due to blockage by brown pigment or blood was intensely dark and well defined when compared with hypoautofluorescence due to loss of pigment epithelium (due to background choroidal AF). Color fundus/red-free images were also used as adjuncts to differentiate lesions, the distinction between melanin and blood was made on the basis of color photographs.
Participants also had a comprehensive dilated ophthalmologic examination during which monocular visual acuity was measured after refraction was performed under a standardized protocol, using the early treatment diabetic retinopathy study logarithm of the minimum angle of resolution visual acuity charts at a distance of 4 m. 24, 27, 28 
Statistical Methods
Grading data variables for fluorescein leakage on the level of the outer capillary meshwork or the RPE, loss of retinal transparency, presence of visible telangiectatic vessels, of blunted retinal veins, of dilated retinal vessels (arteries/capillaries/venules) and for the presence of a break in the ellipsoid zone on OCT were aggregated for the nine subfields of the grading grid into one variable per respective characteristic.
A linear mixed effects model was used with two random intercepts, one for each participant and one for each eye of each participant. A random slope was used for each of the random intercepts. Diagnostic residuals plots were created to test the assumptions of the model. Given the hypothesis generation goal of this investigation, P value of , 0.05 was considered as statistically significant. Analyses were conducted using R v3.3.2 available under a GNU GPL v2 license (R Development Core Team, www.r-project.org).
Results
Pigment area measurements were performed (anonymized and masked from clinical data) in 150 eyes of 75 probands, over time, a total of 754 measurements (eyes · visits) were available for analysis. Fifty-four measurements were excluded because of the lack of matching epidemiological (clinical) information. A further 122 observations from unilateral pigment cases were excluded and 5 observations were excluded because of the lack of phenotypical information (i.e., no gradable imaging), resulting in a sample of 573 observations of 73 probands.
The mean age of participants at baseline was 61.38 years (SD = 8.73), 30 males (41%) and 43 females (59%). Mean visual acuity at baseline was 61.56 letters (SD = 18.19), Snellen visual acuity equivalent: 20/ 50. The follow-up period ranged from 1 to 8 years with a mean of 4.77 years (SD = 2.10).
Mean pigment area at baseline was 0.157 mm 2 (median = 0.0610, range = 0-1.295 mm 2 , SD = 0.228 mm 2 , n = 101). The distribution of pigment area measurements was unimodal and strongly skewed to the right. However, this did not affect the regression modeling. Change over time was positive in all cases (an increase in area).
Results from a linear mixed model revealed a dynamic progression of pigment area at an approximate rate of 0.0177 mm 2 /year (P , 0.001, see Table, Supplemental Digital Content 1, http://links.lww. com/IAE/A710, results of an analysis of pigment plaque area based on a linear mixed model). The growth rate of pigment area seemed to be associated with the initial area size of the pigment plaque. Specifically, we found the pigment area to increase by 0.0618 mm 2 (P , 0.001) faster per year for each unit increment in the initial area size of pigment, indicating an overall nonlinear progression rate. We observed no appreciable differences between right and left eyes (results not shown).
Area being a squared measure, we performed a further linear mixed model to test (assuming circular lesions) whether also the plaque radius progression is dependent on the initial value. 29 The association was not statistically significant (b = 20.0035, SE = 0.0065, degrees of freedom = 104.6188, T-statistics = 20.5381, P = 0.5917). Excluding initial radial lesion size in the next iteration, the increase in lesion radius appeared linear and on average 0.0194 mm annually.
In a second model, we analyzed the relationship between pigment area size and other characteristics (see Table, Supplemental Digital Content 2, http:// links.lww.com/IAE/A711, The effect of other clinical signs on pigment area using a linear mixed model). Loss of retinal transparency and neovascularization were associated with significantly higher pigment area growth rates (b = 0.001, P-value , 0.001) and (b = 0.0156, P-value = 0.036), respectively. Interestingly, vascular signs such as right-angle veins or visible telangiectatic vessels were significantly associated with a reduced growth rate of pigment area (b = 20.0067, P-value , 0.001 and b = 20.001, P-value = 0.032, respectively). In this model, sex, age, and ethnicity did not significantly affect pigment area or its growth (results not shown).
We also performed an analysis of symmetry of pigment area (presented in Table, Supplemental Digital Content 3, http://links.lww.com/IAE/A712). Pigment area size in one eye was strongly correlated with pigment area size in the fellow eye (right eyes P = 0. 0001 and left eyes P , 0.001). We found pigment area to significantly and inversely affect best-corrected visual acuity (see Table, Supplemental Digital Content 4, http://links.lww.com/IAE/A713, The effect of pigment plaque area on visual acuity). A unit (mm 2 ) increment in pigment area decreased visual acuity by 16.1923 early treatment diabetic retinopathy study letters (P = 0.008).
Our study sample was too small for a reliable analysis of the time to transition of unilateral cases of pigment to bilateral, however, based on 15 initially unilateral cases we observed a mean time to bilaterality of 2.32 years (SD = 1.71).
Based on CF and OCT images acquired over time, pigment appears adjacent to and propagates along abnormal blood vessels in the outer retina. Subsequently, it forms a pigment plaque in the midretina that appears to be contiguous with the pigment accumulation in the outer retina (Figures 1 and 2) .
To assess the sequence of occurrence of pigment relative to neovascularization, grading data of both eyes (based on color and FFA images) of 1,244 probands enrolled in the MacTel Natural History Observation and Registry Studies were analyzed in descriptive terms for the presence of clinical signs indicating neovascularization in the present or the past (signs of active SRNV or retinal scar/fibrosis because of earlier SRNV).
Signs of SRNV were present in a total of 150 right eyes (12.1%); of these in 114 (76%) already had SRNV at baseline and in 36 eyes (24%), SRNV developed during the follow-up of the study. In 29 (81%) eyes developing SRNV during follow-up, pigment was observed before the appearance of SRNV, in 7 eyes (19%) it was not. In left eyes, SRNV was present in a total of 118 eyes (9.5%); of these in 86 (73%) had SRNV at baseline. In 32 left eyes (27%), SRNV developed during follow-up and in 22 (69%) of these with pigment already present. In 10 left eyes (31%), SRNV developed without preceding pigment. A detailed review and analysis of the phenotype in all available images of all modalities confirmed the findings of the grading in six right eyes (17%) and seven left eyes (22%), in two of these left eyes SRNV and pigment were first observed at the same visit. In one eye, the typical MacTel pigment developed in a nonadjacent retinal area after SRNV appeared.
Discussion
One characteristic neurodegenerative sign in Type 2 idiopathic macular telangiectasia is the presence of dark brown pigment plaques enveloping blood vessels, typically appearing located to the mid-retina, temporal to the foveal center, 1, 30 as has been well demonstrated in animal models in which Müller cells are involved in the disease process. 4, 5 Before the availability of OCT, the diagnosis of Type 2 MacTel often used to be based on their presence. The perceived significance of pigment plaques is also reflected in the fact that its presence alone drives Stage 4 in the disease severity staging system devised by Gass and Blodi in 1993. 2 Meleth et al 18 noted in a sample of 22 nonneovascular MacTel eyes followed for on average 42.5 months (range = 12-79 months) a linear growth rate of 8.3 ± 1.7 · 10 3 mm 2 /month (mean ± SEM) based on measurements in CF photographs.
In our study, we used Heidelberg Region Finder on grayscale AF images of a sample of overall 150 eyes imaged over a mean follow-up period of 7.8 years. Growth rate in pigment area showed a nonlinear progression pattern at an overall rate of 0.0177 mm 2 / year but with a linear radial progression rate. Differences in methodology, sample size, follow-up period, and analysis methods as well as the lack of a calibration of true retinal image size based on the axial length and refractive power of each eye in either study may explain differences in growth estimates.
The presence of blunted and right-angle veins, that is, blood vessels that traverse the retinal layers at an abnormally steep angle toward the outer retina is characteristic of the phenotype of MacTel Type 2. An increasing number of experimental models suggest that a retinal Müller glial dysfunction or cell death may contribute to the formation of these vessels, possibly through dysregulated lipid and glucose photoreceptor Most of the pigment in this eye is located external to the superficial and deep retinal meshworks, the apparent extent of the pigment is much smaller in the FFA image than in the FAF and CF images. The source of the pigment is hypothesized to be inside cells migrating from the RPE. energy metabolism. 4, [31] [32] [33] According to the current hypotheses of the pathogenesis of pigment plaques, when pigmented cells from the RPE come into contact with these abnormal vessels, the RPE cells use these as a scaffolding and migrate along the vessels into the inner retina, where they start to proliferate and spread ("sideways" away from the vessels) along the retinal layers, approximately on the level of the outer plexiform/inner nuclear layers. This may play a role in the nonlinearity of the growth pattern evident from our data, with a relatively lower growth rate in the phase of perivascular "vertical" migration and an increase in growth rate once the pigment reaches the mid/inner retina and starts proliferating "horizontally"-along the retinal layers away from the vessel walls (Figures 1-3) .
A transmissive "window defect" around the pigment plaques with a central vessel can often be seen (Figures 2 and 3 ) and may be interpreted as indicative of centripetal RPE cell migration toward the vessel at the plaque center, although the sheer mass of pigment plaques suggests cell proliferation as well. The propensity of RPE to ensheathe and migrate along blood vessels is well known and documented in other diseases including retinitis pigmentosa. 34, 35 This pigmentary "sheath" may also provide support for the abnormal blood vessels, decreasing their permeability thus limiting the extent of hemorrhages, while increasing the propensity of the tissue in Type 2 MacTel for fibrosis and tissue contraction. 17 It does not, however, seem to provide a protection from secondary subretinal neovascularization. Consistent with the findings of Meleth et al, 18 our data indicate that in most (on average 75%) cases pigment plaques precede SRNV. Subretinal neovascular proliferation may, however, also appear simultaneously with pigment or with no MacTel-type pigment detectable before the incidence of SRNV. Furthermore, pigment clumps may also be associated with the secondary neovascularization itself and although pigment associated with SRNV has a somewhat different morphology (more convex/ round lesions, smoother convex edges, not immediately adjacent to following the vessels), differentiating pigment secondary to MacTel from that secondary to SRNV can be challenging, and the two types of pigment may even coexist in the same eye. One limitation of our study is that we cannot exclude the possibility that some of the pigment area measured in eyes with neovascularization is in fact part of pigmentation secondary to the neovascular complex itself.
Based on the slow but consistent and linear area growth rate found in their data, Meleth et al concluded that pigment clumping may be a useful indicator of disease severity and an outcome measure for longitudinal studies. Our data also indicate a consistent area growth, but at a nonlinear rate, which demonstrates a strong correlation with initial pigment area. The radial increase in size, however, seems linear. The similarity of SRNV-related pigment to MacTel-type pigment confounds the picture. Neovascularization, driving Stage 5 in the current Gass & Blodi staging system may occur simultaneously with or even precede pigment (which defines Stage 4). All these factors need to be taken into account if pigment clumping is to be used as a measure of disease progression. We expect our data to contribute to refining the current system for staging disease severity.
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